SCHEMBL25925899

SCHEMBL25925899

Cn1nccc1/N=N/c1c(O)c(O)c(/N=N/c2ccnn2C)c2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 3/20 0.35
KMT2A Q03164 6/20 0.33
LMNA P02545 5/20 0.33
HPGD P15428 2/20 0.33
HSP90AA1 P07900 2/20 0.33
NPC1 O15118 2/20 0.33
MPL P40238 2/20 0.33
MEN1 O00255 2/20 0.33
ABCB1 P08183 1/20 0.33
RAB9A P51151 1/20 0.33
S100A4 P26447 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
KDM4E B2RXH2 2/20 0.32
OPRK1 P41145 2/20 0.32
HTT P42858 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925903 0.85
SCHEMBL25925935 0.84 MPL (0.48) MAPTALDH1A1TDP1KMT2ALMNA
SCHEMBL25925901 0.84 MGAM (0.33) MAPTALDH1A1TDP1KMT2AHPGD
SCHEMBL25925905 0.80
SCHEMBL25925733 0.79 ALDH1A1 (0.36) MAPTALDH1A1
SCHEMBL25925932 0.75 ESR1 (0.33) MAPTALDH1A1TDP1KMT2AHSP90AA1
SCHEMBL25925704 0.75 MAPT (0.33) MAPTALDH1A1TDP1KMT2ALMNA
SCHEMBL25925736 0.74 HTT (0.31) MAPTALDH1A1KMT2AHTTSMN1; SMN2
SCHEMBL25925862 0.71 MAPT (0.34) MAPTALDH1A1TDP1KMT2AHSP90AA1
SCHEMBL25925933 0.71 PTGS1 (0.41) MAPTALDH1A1TDP1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 MAPT 2/4885ALDH1A1 580/4885TDP1 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.